Early-phase Study of ART002g1 Injection in HeFH: Safety, Tolerability and Preliminary Efficacy

Clinical trial NCT07353398 · NOT_YET_RECRUITING

Trial details

NCT number: NCT07353398
Sponsor: Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine
Status: NOT_YET_RECRUITING
Phase: Early Phase 1
Study type: INTERVENTIONAL

Heterozygous Familial Hypercholesterolemia

Start date: 2026-03-11
Primary completion: 2027-07-01
Enrollment: 24

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.